Cilofexor not checked

Gilead (Kite) · GS-9674

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
1 active
7 in total
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Primary Biliary Cholangitis
Main trialPhase 2
“The goal of this clinical study is to learn more about the combination of study drugs seladelpar and cilofexor. The study will assess, the safety, tolerability, and effectiveness of the combination drugs versus both seladelpar alone and placebo, in participants with primary biliary cholangitis (PBC). The primary objective of this study is to determine whether the combination of seladelpar + cilofexor leads to greater alkaline phosphatase (ALP) reduction than seladelpar alone and describe the safety and tolerability of seladelpar + cilofexor.”In the company’s words, NCT07841977 on ClinicalTrials.gov
Other names
CILO · GS-9674

Other drugs for Primary Biliary Cholangitis

All 7 drugs for Primary Biliary Cholangitis

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials7

TrialPhaseCompletesWhat it tests
Phase 2Recruiting Dec 2028 Study of Seladelpar and Cilofexor in Participants With Primary Biliary Cholangitis
Phase 3Terminated 10 Nov 2022 Study of Cilofexor in Adults With Primary Sclerosing Cholangitis
Phase 2Completed 28 Feb 2018 Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
Phase 2Completed 13 Jul 2020 Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)
Phase 2Completed 17 Dec 2020 Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)
Phase 1Completed 16 Oct 2018 Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function
Phase 1Terminated 2 Sep 2021 Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Cilofexor

Following is part of Solo: you see every change to Cilofexor the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in